Literature DB >> 15322126

Role of betaAsn-243 in the phosphate-binding subdomain of catalytic sites of Escherichia coli F(1)-ATPase.

Zulfiqar Ahmad1, Alan E Senior.   

Abstract

In the catalytic mechanism of ATP synthase, phosphate (P(i)) binding and release steps are believed to be correlated to gamma-subunit rotation, and P(i) binding is proposed to be prerequisite for binding ADP in the face of high cellular [ATP]/[ADP] ratios. In x-ray structures, residue betaAsn-243 appears centrally located in the P(i)-binding subdomain of catalytic sites. Here we studied the role of betaAsn-243 in Escherichia coli ATP synthase by mutagenesis to Ala and Asp. Mutation betaN243A caused 30-fold impairment of F(1)-ATPase activity; 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole inhibited this activity less potently than in wild type and P(i) protected from inhibition. ADP-fluoroaluminate was more inhibitory than in wild-type, but ADP-fluoroscandium was less inhibitory. betaN243D F(1)-ATPase activity was impaired by 1300-fold and was not inhibited by ADP-fluoroaluminate or ADP-fluoroscandium. 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole activated betaN243D F(1)-ATPase, and P(i) did not affect activation. We conclude that residue betaAsn-243 is not involved in P(i) binding directly but is necessary for correct organization of the transition state complex through extensive involvement in hydrogen bonding to neighboring residues. It is also probably involved in orientation of the "attacking water" and of an associated second water.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322126     DOI: 10.1074/jbc.M407608200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner.

Authors:  Nagababu Chinnam; Prasanna K Dadi; Shahbaaz A Sabri; Mubeen Ahmad; M Anaul Kabir; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2010-03-25       Impact factor: 6.953

Review 2.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  Effect of structural modulation of polyphenolic compounds on the inhibition of Escherichia coli ATP synthase.

Authors:  Zulfiqar Ahmad; Mubeen Ahmad; Florence Okafor; Jeanette Jones; Abdelmajeed Abunameh; Rakesh P Cheniya; Ismail O Kady
Journal:  Int J Biol Macromol       Date:  2012-01-20       Impact factor: 6.953

Review 4.  Zooming in on ATP hydrolysis in F1.

Authors:  Markus Dittrich; Klaus Schulten
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 2.945

5.  ATP hydrolysis in Eg5 kinesin involves a catalytic two-water mechanism.

Authors:  Courtney L Parke; Edward J Wojcik; Sunyoung Kim; David K Worthylake
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

6.  Real-time structural transitions are coupled to chemical steps in ATP hydrolysis by Eg5 kinesin.

Authors:  Bokkyoo Jun; Sunyoung Kim
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

Review 7.  Two ATPases.

Authors:  Alan E Senior
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 8.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  Functional importance of αIle-346 and αIle-348 in the catalytic sites of Escherichia coli ATP synthase.

Authors:  Chao Zhao; Hiba Syed; Sherif S Hassan; Vineet K Singh; Zulfiqar Ahmad
Journal:  Arch Biochem Biophys       Date:  2016-01-14       Impact factor: 4.013

10.  Studies of nucleotide binding to the catalytic sites of Escherichia coli betaY331W-F1-ATPase using fluorescence quenching.

Authors:  Vladimir V Bulygin; Yakov M Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.